PortfoliosLab logoPortfoliosLab logo
DOCG.L vs. DRDR.L
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

DOCG.L vs. DRDR.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in L&G Healthcare Breakthrough UCITS ETF (DOCG.L) and iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

DOCG.L vs. DRDR.L - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
DOCG.L
L&G Healthcare Breakthrough UCITS ETF
-8.11%16.50%3.57%-6.64%-25.94%1.46%63.33%0.69%
DRDR.L
iShares Healthcare Innovation UCITS ETF USD (Acc)
-3.14%10.25%2.62%-2.51%-14.93%-5.21%48.69%0.75%

Returns By Period

In the year-to-date period, DOCG.L achieves a -8.11% return, which is significantly lower than DRDR.L's -3.14% return.


DOCG.L

1D
0.82%
1M
-8.16%
YTD
-8.11%
6M
8.74%
1Y
17.96%
3Y*
0.93%
5Y*
-4.99%
10Y*

DRDR.L

1D
1.51%
1M
-5.29%
YTD
-3.14%
6M
7.57%
1Y
14.45%
3Y*
3.07%
5Y*
-2.01%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


DOCG.L vs. DRDR.L - Expense Ratio Comparison

DOCG.L has a 0.49% expense ratio, which is higher than DRDR.L's 0.40% expense ratio.


Return for Risk

DOCG.L vs. DRDR.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCG.L
DOCG.L Risk / Return Rank: 4242
Overall Rank
DOCG.L Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
DOCG.L Sortino Ratio Rank: 4747
Sortino Ratio Rank
DOCG.L Omega Ratio Rank: 3939
Omega Ratio Rank
DOCG.L Calmar Ratio Rank: 4242
Calmar Ratio Rank
DOCG.L Martin Ratio Rank: 3636
Martin Ratio Rank

DRDR.L
DRDR.L Risk / Return Rank: 4545
Overall Rank
DRDR.L Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
DRDR.L Sortino Ratio Rank: 4646
Sortino Ratio Rank
DRDR.L Omega Ratio Rank: 4040
Omega Ratio Rank
DRDR.L Calmar Ratio Rank: 5050
Calmar Ratio Rank
DRDR.L Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DOCG.L vs. DRDR.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Breakthrough UCITS ETF (DOCG.L) and iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DOCG.LDRDR.LDifference

Sharpe ratio

Return per unit of total volatility

0.84

0.84

0.00

Sortino ratio

Return per unit of downside risk

1.29

1.24

+0.06

Omega ratio

Gain probability vs. loss probability

1.16

1.16

0.00

Calmar ratio

Return relative to maximum drawdown

1.09

1.27

-0.19

Martin ratio

Return relative to average drawdown

3.29

3.69

-0.40

DOCG.L vs. DRDR.L - Sharpe Ratio Comparison

The current DOCG.L Sharpe Ratio is 0.84, which is comparable to the DRDR.L Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of DOCG.L and DRDR.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


DOCG.LDRDR.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.84

0.84

0.00

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.23

-0.11

-0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

0.17

0.33

-0.16

Correlation

The correlation between DOCG.L and DRDR.L is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

DOCG.L vs. DRDR.L - Dividend Comparison

Neither DOCG.L nor DRDR.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DOCG.L vs. DRDR.L - Drawdown Comparison

The maximum DOCG.L drawdown since its inception was -51.45%, which is greater than DRDR.L's maximum drawdown of -38.49%. Use the drawdown chart below to compare losses from any high point for DOCG.L and DRDR.L.


Loading graphics...

Drawdown Indicators


DOCG.LDRDR.LDifference

Max Drawdown

Largest peak-to-trough decline

-51.45%

-38.49%

-12.96%

Max Drawdown (1Y)

Largest decline over 1 year

-15.66%

-11.00%

-4.66%

Max Drawdown (5Y)

Largest decline over 5 years

-49.65%

-35.81%

-13.84%

Current Drawdown

Current decline from peak

-33.67%

-20.29%

-13.38%

Average Drawdown

Average peak-to-trough decline

-26.99%

-15.08%

-11.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.17%

3.79%

+1.38%

Volatility

DOCG.L vs. DRDR.L - Volatility Comparison

L&G Healthcare Breakthrough UCITS ETF (DOCG.L) has a higher volatility of 6.30% compared to iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) at 5.39%. This indicates that DOCG.L's price experiences larger fluctuations and is considered to be riskier than DRDR.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


DOCG.LDRDR.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.30%

5.39%

+0.91%

Volatility (6M)

Calculated over the trailing 6-month period

14.05%

10.80%

+3.25%

Volatility (1Y)

Calculated over the trailing 1-year period

21.34%

17.09%

+4.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.92%

17.62%

+4.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.40%

18.59%

+4.81%